Pharmd Candidate News Today

/PRNewswire/ -- Intern alumni from Moda Health and Novo Nordisk Inc. join forces with the AMCP Foundation for a groundbreaking Health Disparities research...

Intern alumni from Moda Health and Novo Nordisk Inc. join forces with the AMCP Foundation for a groundbreaking Health Disparities research internship, appointing Daria Sinclair, a PharmD Candidate at Howard University, College of Pharmacy, as the...

Aducanumab, lecanemab, and donanemab are novel monoclonal antibodies designed to slow disease progression and hopefully have a positive impact in the field of Alzheimer disease management.

Patients often turn to dietary supplements for the management of osteoarthritis, one of which is turmeric.

It is vital for health care teams to recognize the signs and symptoms of antiphospholipid syndrome and to identify the severity of a patient’s diagnosis based on their aPL profile.

An increase in cannabis use has led to growing concerns surrounding interactions between its components, THC and CBD, and prescription medications.

The estimated cost burden of schizophrenia is more than $150 billion, consisting of direct treatment cost and lost productivity.

Since the 2018 guideline’s publication, additional non-statin therapies such as bempedoic acid, evinacumab, and inclisiran, have been approved by the FDA for the management of hypercholesterolemia.

Pharmacists are crucial in supporting patients with attention-deficit hyperactivity disorder as shortages of Adderall continue.

/PRNewswire/ -- AMCP Foundation and CVS Health announced the recipients of AMCP Foundations Best Poster Awards at AMCP 2023. This semiannual competition...